Uncategorized
Santen to purchase Merck’s ophthalmology products in Japan and Europe, Asia-Pacific markets
Santen Pharmaceutical and Merck have entered into an agreement by which Santen will purchase Merck’s ophthalmology products in Japan and key markets in Europe and the Asia-Pacific. Under the agreement, Santen will purchase Cosopt (dorzolamide hydrochloride–timolol maleate ophthalmic solution), Cosopt PF (dorzolamide hydrochloride-timolol maleate ophthalmic solution 2%/0.5%), Trusopt (dorzolamide hydrochloride ophthalmic solution sterile ophthalmic solution 2%)